Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Textos de Ayuda para la Intervención en el Duelo de Estudiantes Universitarios Afligidos

5 de noviembre de 2026 actualizado por: Ted Robles, PhD, University of California, Los Angeles

Textos de Ayuda Intervención en Duelo para Estudiantes Universitarios en Duelo

The proposed study aims to evaluate the effectiveness of Help Texts, a weekly text-based program, among bereaved students at UCLA. Specifically, the study will evaluate whether Help Texts reduces grief severity and symptoms of depression, and whether it improves academic functioning (e.g., graduation, grades, student enrollment retention).

The investigators hypothesize that bereaved UCLA students who receive a 12-month Help Texts weekly digital text intervention will have reduced grief severity and depressive symptoms and increased academic functioning compared to bereaved UCLA students in a waitlist control condition receiving treatment as usual (i.e., list of resources for grief).

Participants will complete surveys at four timepoints: baseline and 3 months, 6 months, and 12 months following enrollment. They will be randomly assigned to either the treatment condition (receive 12-month Help Texts subscription at enrollment) or the waitlist control condition (receive list of resources for grief at enrollment, and receive 12-month Help Texts subscription at 6 months following enrollment). The Help Texts program involves texts offering psychoeducation related to grief and coping strategies, delivered twice weekly.

Descripción general del estudio

Descripción detallada

Grief and loss are common occurrences among students on college campuses but are inadequately addressed and associated with a number of negative outcomes. A mixed methods study of grieving students on a large campus found that 60% of those surveyed within a 3-year period at UCLA reported experiencing the loss of a loved one, but only 8% reported using campus resources to aid them during their grief, and only 38% sought resources off-campus (e.g., therapy, support groups, psychiatry). Numerous barriers to accessing grief support resources have been identified, including not knowing about them or perceiving them to be inadequate. Moreover, over one-third of participants interviewed in the study noted stigma associated with help-seeking. Despite a high prevalence of experiences of grief among students, resource utilization for supporting bereavement remains low.

Help Texts offers text message-based grief support, overcoming the barriers of access and stigma by providing up to a year of private, evidence-based grief support developed by clinical psychologists. Help Texts is an established company (specifically, a Public Benefit Corporation) and is currently in use. It was founded in 2018 and comprises a fully remote, 7-person team with over 100+ additional Expert Contributors providing expertise on different types of loss (e.g., the loss of a sibling, child, parent, partner; loss to cancer, dementia, suicide, COVID-19, etc); and the unique risks associated with being a caregiver, veteran, or member of the LGBTQIA2S+ or Black, Indigenous, and People of Color (BIPOC) communities. Help Texts is delivering support in 57 countries, in all 50 states in the U.S., and in 27 languages.

Help Texts provides twice-weekly, one-way texts offering basic grief education by normalizing and validating the grief experience and then offering tips for coping within various themes around grief. Preliminary evidence suggests that bereaved users of HelpTexts have found it supportive; 95% of all users rated their satisfaction with HelpTexts as a 4 or 5 out of 5 and found the text messages helpful. The proposed study is a randomized control trial that aims to evaluate the effectiveness of Help Texts to grieving students at UCLA in reducing grief severity and symptoms of depression, preventing prolonged grief and major depressive disorder, and in improving quality of life and occupational functioning (e.g., graduation, grades, student enrollment retention).

Tipo de estudio

Intervencionista

Inscripción (Estimado)

126

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Michelle Chang, M.A., C.Phil
  • Número de teléfono: (323) 284-4695
  • Correo electrónico: changmichelle@g.ucla.edu

Copia de seguridad de contactos de estudio

  • Nombre: Theodore F. Robles, Ph.D.
  • Número de teléfono: (310) 794-9362
  • Correo electrónico: robles@psych.ucla.edu

Ubicaciones de estudio

    • California
      • Los Angeles, California, Estados Unidos, 90095
        • Reclutamiento
        • Franz Hall
        • Contacto:
          • Michelle Chang, M.A.
          • Número de teléfono: 3232844695
          • Correo electrónico: griefstudy@ucla.edu
        • Investigador principal:
          • Theodore Robles, Ph.D.

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Enrolled UCLA student
  • At least 18 years old
  • Experienced death of a close person in the past 12 months
  • Able to read English

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Otro: Waitlist Control with Treatment as Usual

At study enrollment, participants receive treatment as usual--a list of resources relevant to grief.

At 6 months following study enrollment, participants will receive a 12-month subscription to Help Texts, a text-based intervention that delivers two texts per week providing bereavement psychoeducation, validation, and coping strategies.

Participants will receive treatment as usual, consisting of a list of resources for coping with grief both on-campus and off-campus

Help Texts delivers texts twice a week over a period of 12-months to provide psychoeducation, validation, and coping strategies relevant to bereavement. The The texts offer some customization in specifying the name of the participant and their deceased loved one, as well as providing texts relevant to the participants' cause of bereavement and relationship to their deceased loved one.

Otros nombres:
  • Textos de Ayuda
Comparador activo: Treatment

At study enrollment, participants will receive a 12-month subscription to Help Texts, a text- based intervention that delivers two texts per week providing bereavement psychoeducation, validation, and coping strategies.

Help Texts delivers texts twice a week over a period of 12-months to provide psychoeducation, validation, and coping strategies relevant to bereavement. The The texts offer some customization in specifying the name of the participant and their deceased loved one, as well as providing texts relevant to the participants' cause of bereavement and relationship to their deceased loved one.

Otros nombres:
  • Textos de Ayuda

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Prolonged Grief Disorder-Revised (PG-13-R)
Periodo de tiempo: 0 months, 3 months, 6 months, 12 months following enrollment

PG-13-R measures symptoms of Prolonged Grief Disorder (PGD) mapping onto the Diagnostic and Statistical Manual's conceptualization of clinical grief. The measure assesses symptoms such as yearning for the deceased close person, avoiding reminders of their death, and feelings of loneliness in relation to the death. Each item is rated from 1 (Not at all) to 5 (Overwhelmingly). Total scores range from 10 to 50, with higher scores representing more severe prolonged grief.

0 months, 3 months, 6 months, 12 months following enrollment
Patient Health Questionnaire (PHQ-3)
Periodo de tiempo: 0 months, 3 months, 6 months, 12 months following enrollment

The PHQ-3 measures symptoms of depression over the last 2 weeks, including loss of interest in things, feeling down or hopeless, and feeling tired. Each item is rated from 0 (Not at all) to 3 (Nearly every day). Total scores range from 0 to 9, with higher scores representing more severe symptoms of depression.

0 months, 3 months, 6 months, 12 months following enrollment

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Academic Functioning - GPA
Periodo de tiempo: 0 months, 3 months, 6 months, 12 months following enrollment

Participants' current overall GPA will be measured. From highest to lowest, the GPA options will be the following: A+, A, A-, B+, B, B-, C+, C, C-, D+ or below, with A+ representing the highest possible current overall GPA.

0 months, 3 months, 6 months, 12 months following enrollment
Academic Functioning - Negative Impacts to Academic Performance
Periodo de tiempo: 0 months, 3 months, 6 months, 12 months following enrollment

The investigators will assess the number of days that participants felt that emotional or mental difficulties hurt their academic performance. Participants can select the following options: None (0), 1-2 days (1), 3-5 days (2), 6 or more days (3), with scores ranging from 0 to 3. Higher scores indicate more days that participants felt their academic performance was hurt by their emotional or mental difficulties.

0 months, 3 months, 6 months, 12 months following enrollment
Academic Functioning - Class Enrollment Status
Periodo de tiempo: 0 months, 3 months, 6 months, 12 months following enrollment

Participants will indicate whether or not they are currently registered for classes at UCLA. They will respond Yes (1) or No (0), with a higher score indicating that they are currently registered for classes.

0 months, 3 months, 6 months, 12 months following enrollment
Academic Functioning - Dropped Course
Periodo de tiempo: 0 months, 3 months, 6 months, 12 months following enrollment

Another academic outcome measured will be whether or not participants dropped a course in the past quarter. This will be dichotomously scored as Yes (1) or No (0), with a higher score indicating endorsement of having dropped a course in the past quarter.

0 months, 3 months, 6 months, 12 months following enrollment

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Generalized Anxiety Disorder-7 (GAD-7)
Periodo de tiempo: 0 months, 3 months, 6 months, 12 months following enrollment

The GAD-7 will assess symptoms of generalized anxiety over the past 2 weeks consistent with the Diagnostic and Statistical Manual's conceptualization of generalized anxiety. It will assess symptoms such as being unable to control worrying and having difficulty relaxing. Items will be scored from 0 (Not at all) to 3 (Nearly every day). Total scores will range from 0 to 21, with higher scores indicating more severe symptoms of generalized anxiety.

0 months, 3 months, 6 months, 12 months following enrollment

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

30 de octubre de 2025

Finalización primaria (Estimado)

1 de junio de 2027

Finalización del estudio (Estimado)

1 de junio de 2027

Fechas de registro del estudio

Enviado por primera vez

23 de septiembre de 2025

Primero enviado que cumplió con los criterios de control de calidad

12 de noviembre de 2025

Publicado por primera vez (Actual)

14 de noviembre de 2025

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

6 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

5 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • IRB-25-0709

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Our data will be securely managed by members of our research team and will not be shared with members outside of our research team. Findings from our research will be summarized and shared such that participants are not individually identifiable. Should other collaborators desire to access our data, they will need to be aligned with the goals of our research and added and approved to our IRB protocol.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir